2-phenyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one | 19819-18-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并嘧啶酮衍生物
• 英文名称: 2-phenyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one
• 英文别名: 2-phenyl-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-4-one
• CAS: 19819-18-2
• 化学式: C₁₆H₁₄N₂OS
• 分子量: 282.366
• InChiKey: CDFWRIZOSNAGCV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  20
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  69.7
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 储存条件：
  -20°C

制备方法与用途

抗增殖剂-15是一种抗癌药物，能够抑制多种癌细胞系的生长。研究显示，它对人类结肠癌（HCT116和HCT15）以及脑癌（LN-229和GBM-10）细胞系具有显著的抗增殖活性。

反应信息

• 作为反应物：
  描述：

  2-phenyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one 在 四丁基碘化铵 间氯过氧苯甲酸 、 三氯氧磷 作用下， 以 氯仿 、 水 、 苯 为溶剂， 反应 18.0h， 生成 4-mesyl-2-phenyl-5,6,7,8-tetrahydro<1>benzothieno<2,3-d>pyrimidine
  参考文献：
  名称：

  Yamaguchi, Hitoshi; Ishikawa, Fumiyoshi, Chemical and pharmaceutical bulletin, 1982, vol. 30, # 1, p. 326 - 332

  摘要：

  DOI：
• 作为产物：
  描述：

  2-苯基-5,6,7,8-四氢-4H-[1]苯并噻吩并[2,3-d][1,3]恶嗪-4-酮 在 formamide 作用下， 反应 0.08h， 以90%的产率得到2-phenyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one
  参考文献：
  名称：

  Synthesis of Some New Tetrahydrobenzo[b]thiophene Derivatives and Tetrahydrobenzothienopyrimidine Derivatives Under Microwave Irradiation

  摘要：

  2-Phenyl-5,6,7,8-tetrahydro-4H-benzothieno[2,3-d][1,3]oxazin-4-one (4) was reacted with either aliphatic or aromatic primary amines such as benzylamine, cyclohexylamine, p-toluidine, and/or p-anisidine to give carboxamide derivatives 5a-d, respectively. A bifunctional nucleophile such as ethanolamine was also reacted with 4, giving the carboxamide derivative 5e. Aminolysis of 4 with secondary amines such as piperidine and/or morpholine afforded the benzamide derivatives 6a and/or 6b, respectively. Fusion of 4 with hydrazine hydrate yielded the pyrimidine derivative 7 and carbohydrazide derivative 8. Thiation of 4 with phosphorous pentasulfide gave thienothiazine derivative 9, which reacted with benzylamine to give the pyrimidine derivative 10. Carbon nucleophiles such as ethyl cyanoacetate and/or malononitrile were subjected to react with 4 to give oxopropanoate 11 and/or oxopropanoic acid 12 derivatives, respectively. Microwave irradiation of 4 and formamide yielded the pyrimidinone derivative 13, which were subjected to react with phosphorous pentasulfide, a mixture of phosphorous oxychloride and phosphorous pentachloride and/or methyl iodide, to give 14, 15, and/or 16, respectively.

  DOI：

  10.1080/00397911.2010.501479

文献信息

• Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents
  作者：Yuan Zhang、Lu Luo、Chao Han、Handeng Lv、Di Chen、Guoliang Shen、Kaiqi Wu、Suwei Pan、Faqing Ye

  DOI：10.3390/molecules22111960

  日期：——

  findings suggest that A2, A6 and B7 may operate as an effective anti-inflammatory agent through inhibiting the activation of NF-κB and MAPK signaling pathways in macrophages. Moreover, rat paw swelling experiments showed that these compounds possess anti-inflammatory activity in vivo, with compound A6 exhibiting similar activities to the reference drug Indomethacin.

  我们设计并合成了 26 种原型化合物，并研究了它们的抗炎活性和潜在的分子机制。这些化合物对脂多糖 (LPS) 刺激的巨噬细胞中一氧化氮 (NO)、细胞因子、炎症相关蛋白和 mRNA 的产生的抑制作用通过 Griess 试验、酶联免疫吸附试验 (ELISA)、蛋白质印迹法测定分析和逆转录聚合酶链反应 (RT-PCR) 分别进行。我们的结果表明，用 A2、A6 和 B7 处理显着抑制了 RAW264.7 细胞中 NO 和炎性细胞因子的分泌，而没有明显的细胞毒性。还发现A2、A6和B7强烈抑制诱导型一氧化氮合酶（iNOS）和环氧合酶COX-2的表达，并通过抑制 p50 和 IκBα 的降解来阻止核因子 κB (NF-κB) p65 的核易位。此外，A2、A6 和 B7 显着抑制了 LPS 刺激的 RAW264.7 细胞中丝裂原活化蛋白激酶 (MAPK) 的磷酸化。这些发现表明 A2、A6 和 B7
• <i>ortho</i>-Naphthoquinone-catalyzed aerobic oxidation of amines to fused pyrimidin-4(3<i>H</i>)-ones: a convergent synthetic route to bouchardatine and sildenafil
  作者：Kyeongha Kim、Hun Young Kim、Kyungsoo Oh

  DOI：10.1039/d0ra06820a

  日期：——

  A facile access to fused pyrimidin-4(3H)-one derivatives has been established by using the metal-free ortho-naphthoquinone-catalyzed aerobic cross-coupling reactions of amines. The utilization of two readily available amines allowed a direct coupling strategy to quinazolinone natural product, bouchardatine, as well as sildenafil (Viagra™) in a highly convergent manner.

  通过使用无金属邻萘醌催化的胺有氧交叉偶联反应，已经建立了一种容易获得稠合 pyrimidin-4(3 H )-one 衍生物的方法。利用两种容易获得的胺，可以以高度收敛的方式直接偶联喹唑啉酮天然产物布沙达汀和西地那非 (Viagra™)。
• Discovery of Thieno[2,3-<i>d</i>]pyrimidine-Based Hydroxamic Acid Derivatives as Bromodomain-Containing Protein 4/Histone Deacetylase Dual Inhibitors Induce Autophagic Cell Death in Colorectal Carcinoma Cells
  作者：Zhaoping Pan、Xiang Li、Yujia Wang、Qinglin Jiang、Li Jiang、Min Zhang、Nan Zhang、Fengbo Wu、Bo Liu、Gu He

  DOI：10.1021/acs.jmedchem.9b02178

  日期：2020.4.9

  Bromodomain-containing protein 4 (BRD4) and histone deacetylases (HDAC) are both attractive epigenetic targets in cancer and other chronic diseases. Based on the integrated fragment-based drug design, synthesis, and in vitro and in vivo evaluations, a series of novel thieno[2,3-d]pyrimidine-based hydroxamic acid derivatives are discovered as selective BRD4–HDAC dual inhibitors. Compound 17c is the

  含溴结构域的蛋白质4（BRD4）和组蛋白脱乙酰基酶（HDAC）都是癌症和其他慢性疾病中有吸引力的表观遗传学靶标。基于整合的基于片段的药物设计，合成以及体外和体内评估，发现了一系列新型的基于噻吩并[2,3 - d ]嘧啶的异羟肟酸衍生物，作为选择性的BRD4-HDAC双重抑制剂。化合物17c是BRD4和HDAC的最有效抑制剂，其IC 50值在纳摩尔水平以及c-Myc的表达水平，并增加组蛋白H3的乙酰化。而且17c通过诱导自噬细胞死亡，对大肠癌（CRC）细胞的增殖具有抑制作用。它还在大鼠中具有良好的药代动力学特征，口服生物利用度为40.5％。在HCT-116异种移植体内模型中，17c通过诱导自噬细胞死亡并抑制IL6-JAK-STAT信号通路，对肿瘤的生长表现出有效的抑制作用。我们的结果表明，BRD4-HDAC双重抑制可能是CRC的一种有吸引力的治疗策略。
• Multistep, Microwave Assisted, Solvent Free Synthesis and Antibacterial Activity of 6-Substituted-2,3,4-trihydropyrimido[1,2-c]9,10,11,12-tetrahydrobenzo[b]thieno[3,2-e]pyrimidines
  作者：Mailavaram Raghu Prasad、Deb Pran Kishore

  DOI：10.1248/cpb.55.776

  日期：——

  by microwave irradiation of equimolar mixture of 4-hydroxythieno[2,3-d]pyrimidines and phosphorus oxychloride. The final compounds were screened for antibacterial activity by Kirby Bauer's method using amicacin as the standard against various gram positive and gram negative bacteria. All the compounds showed antibacterial activity comparable with the standard.

  一种新颖，高效的微波辅助路线，用于合成6-取代的2,3,4-三氢嘧啶[1,2-c] -9,10,11,12-四氢苯并[b]噻吩并[3,2-e已经开发了高产率的]嘧啶。中间体2-取代的4- [3-羟基（丙基-1-氨基）] 5,6,7,8-四氢苯并[b]噻吩并[2,3-d]嘧啶是通过照射2-取代的-在碱性条件下，在微波炉中，将4-氯-5,6,7,8-四氢苯并[b]噻吩并[2,3-d]嘧啶与1-氨基丙醇一起使用。通过微波辐射4-羟基噻吩并[2,3-d]嘧啶和氯氧化磷的等摩尔混合物，合成了4-氯噻吩并[2,3-d]嘧啶。使用氨苄青霉素作为标准品，针对多种革兰氏阳性和革兰氏阴性细菌，通过柯比鲍尔（Kirby Bauer）方法筛选最终化合物的抗菌活性。
• ZnO-CeO2 nanocomposite: efficient catalyst for the preparation of thieno[2,3-d]pyrimidin-4(3H)-one derivatives
  作者：Farzaneh Ghayour、Mohammad Reza Mohammad Shafiee、Majid Ghashang

  DOI：10.1515/mgmc-2017-0038

  日期：2018.4.13

  mean particle size of the nanocomposite determined by dynamic light scattering technique was 58 nm. The catalytic activity of ZnO-CeO2 nanocomposite was examined on the synthesis of thieno[2,3-d]pyrimidin-4(3H)-one derivatives. In all cases, the products were obtained in good to excellent yields.

  摘要 采用共沉淀法制备氧化锌-氧化铈(ZnO-CeO2)纳米复合材料，并通过X射线衍射(XRD)、场发射扫描电子显微镜(FE-SEM)和粒度分布分析对其进行表征。XRD图显示氧化铈的立方相作为主要相。FE-SEM 图像显示了样品中氧化锌和氧化铈的均匀性分布。通过动态光散射技术测定的纳米复合材料的平均粒径为 58 nm。ZnO-CeO2 纳米复合材料的催化活性在噻吩并[2,3-d]嘧啶-4(3H)-one 衍生物的合成中进行了检测。在所有情况下，产品都以良好到极好的收率获得。